Gene expression profiling of 3D organoids harboring LRRK2-G2019S mutation revealed thiol-oxidoreductase (TXNIP) as one of the upregulated genes and inhibition of TXNIP rescued PD pathology in organoids [35]. This evidence concerns the gene TXNIP and Parkinson disease.